BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22548902)

  • 1. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Fuentes-Casiano E; Bialko CS; Cassidy KA
    Bipolar Disord; 2012 May; 14(3):291-300. PubMed ID: 22548902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Williams TD; Bialko CS; Cassidy KA
    Psychiatr Serv; 2012 Feb; 63(2):176-8. PubMed ID: 22302337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder.
    Sajatovic M; Levin JB; Ramirez LF; Cassidy KA; McNamara N; Fuentes-Casiano E; Wilson B; Appling D; S FB
    Prim Care Companion CNS Disord; 2021 Sep; 23(5):. PubMed ID: 34534421
    [No Abstract]   [Full Text] [Related]  

  • 5. Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder.
    Sajatovic M; Levin JB; Sams J; Cassidy KA; Akagi K; Aebi ME; Ramirez LF; Safren SA; Tatsuoka C
    Bipolar Disord; 2015 Sep; 17(6):653-61. PubMed ID: 26529124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence.
    Sajatovic M; Levin JB; Modi A; McVoy M; Forthun LF; Cooley R; Black J; Conroy C; Sarna K; Briggs FB; DelBello M
    Psychopharmacol Bull; 2023 Aug; 53(3):8-21. PubMed ID: 37601085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.
    Levin JB; Tatsuoka C; Cassidy KA; Aebi ME; Sajatovic M
    Compr Psychiatry; 2015 Apr; 58():29-36. PubMed ID: 25617964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Differences in Medication Adherence, Symptoms, and Stigma in Poorly Adherent Adults With Bipolar Disorder.
    Smilowitz S; Aftab A; Aebi M; Levin J; Tatsuoka C; Sajatovic M
    J Geriatr Psychiatry Neurol; 2020 Sep; 33(5):250-255. PubMed ID: 31542988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder.
    Sajatovic M; Micula-Gondek W; Tatsuoka C; Bialko C
    Gend Med; 2011 Aug; 8(4):261-8. PubMed ID: 21763217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.
    Levin JB; Briggs F; Blixen C; Bauer M; Einstadter D; Albert JM; Weise C; Woods N; Fuentes-Casiano E; Cassidy KA; Rentsch J; Sarna K; Sajatovic M
    Trials; 2022 Aug; 23(1):634. PubMed ID: 35927740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication.
    Sajatovic M; Levin J; Fuentes-Casiano E; Cassidy KA; Tatsuoka C; Jenkins JH
    Compr Psychiatry; 2011; 52(3):280-7. PubMed ID: 21497222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change.
    Ball JR; Mitchell PB; Corry JC; Skillecorn A; Smith M; Malhi GS
    J Clin Psychiatry; 2006 Feb; 67(2):277-86. PubMed ID: 16566624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
    BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program.
    Rosa AR; Reinares M; Amann B; Popovic D; Franco C; Comes M; Torrent C; Bonnín CM; Solé B; Valentí M; Salamero M; Kapczinski F; Vieta E
    Bipolar Disord; 2011; 13(7-8):679-86. PubMed ID: 22085481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.
    Mbwambo J; Kaaya S; Lema I; Burant CJ; Magwiza C; Madundo K; Njiro G; Blixen CE; Cassidy KA; Levin JB; Sajatovic M
    BMC Psychiatry; 2022 Jan; 22(1):62. PubMed ID: 35086504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.
    Patel NC; DelBello MP; Kowatch RA; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):327-35. PubMed ID: 16768640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Comorbid Anxiety With Medication Adherence and Psychiatric Symptomatology in a Population of Nonadherent Bipolar Disorder Subjects.
    Aftab A; Levin J; Aebi M; Bhat C; Sajatovic M
    J Nerv Ment Dis; 2018 Apr; 206(4):258-262. PubMed ID: 29351117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.